In parallel, overexpression of c-Myc resulted in increased MM cell viability, which was reversed by concurrent si-c-Myc transfection or MX69 treatment (Supplemental Figure S7C(below),D(below)). This evidence concerns the gene MYC and Miyoshi myopathy.